ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
9.47
+0.06 (0.64%)
Aug 14, 2026, 4:00 PM EDT - Market closed
ADMA Biologics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 136.02 | 87.63 | 103.15 | 51.35 | 86.52 | 51.09 |
Cash & Short-Term Investments | 136.02 | 87.63 | 103.15 | 51.35 | 86.52 | 51.09 |
Cash Growth | 50.66% | -15.04% | 100.86% | -40.65% | 69.36% | -8.64% |
Receivables | 138.23 | 158.43 | 50 | 27.42 | 15.51 | 28.58 |
Inventory | 239.31 | 206.47 | 170.24 | 172.91 | 163.28 | 124.72 |
Prepaid Expenses | 14.64 | 7.46 | 8.03 | 5.33 | 5.1 | 4.34 |
Other Current Assets | - | 6.53 | - | - | - | - |
Total Current Assets | 528.2 | 466.51 | 331.41 | 257.01 | 270.4 | 208.73 |
Property, Plant & Equipment | 72.81 | 71.71 | 63.34 | 63.47 | 68.75 | 58.2 |
Goodwill | 3.53 | 3.53 | 3.53 | 3.53 | 3.53 | 3.53 |
Other Intangible Assets | 0.58 | 0.63 | 0.46 | 0.5 | 1.01 | 1.73 |
Long-Term Deferred Tax Assets | 69.97 | 73.26 | 84.28 | - | - | - |
Other Long-Term Assets | 9.13 | 8.6 | 5.66 | 4.67 | 4.77 | 4.07 |
Total Assets | 684.21 | 624.24 | 488.68 | 329.18 | 348.46 | 276.25 |
Accounts Payable | 31.72 | 22.52 | 20.22 | 15.66 | 13.23 | 12.43 |
Accrued Expenses | 28.11 | 27.68 | 28.63 | 30.55 | 23.19 | 16.23 |
Current Portion of Long-Term Debt | 3.75 | 2.81 | - | - | - | - |
Current Portion of Leases | 1.18 | 1.1 | 1.22 | 1.05 | 0.91 | 0.59 |
Current Income Taxes Payable | 6.22 | 8.62 | 3.48 | - | - | - |
Current Unearned Revenue | - | - | - | 0.18 | 0.14 | 0.14 |
Other Current Liabilities | 4.78 | 6.82 | 2 | 2.37 | 1.8 | 0.98 |
Total Current Liabilities | 75.76 | 69.54 | 55.54 | 49.81 | 39.27 | 30.38 |
Long-Term Debt | 192.84 | 69.33 | 72.34 | 130.59 | 142.83 | 94.87 |
Long-Term Leases | 6.07 | 6.65 | 8.56 | 9.78 | 10.7 | 7.46 |
Long-Term Unearned Revenue | 1.33 | 1.41 | 1.55 | 1.69 | 1.83 | 1.98 |
Other Long-Term Liabilities | - | - | 1.67 | 2.11 | 1.85 | 0.4 |
Total Liabilities | 276 | 146.92 | 139.66 | 193.98 | 196.49 | 135.08 |
Common Stock | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
Additional Paid-In Capital | 675.14 | 671.04 | 657.58 | 641.44 | 629.97 | 553.27 |
Retained Earnings | -78.5 | -161.65 | -308.58 | -506.26 | -478.02 | -412.11 |
Treasury Stock | -188.45 | -32.09 | - | - | - | - |
Shareholders' Equity | 408.21 | 477.32 | 349.02 | 135.21 | 151.97 | 141.17 |
Total Liabilities & Equity | 684.21 | 624.24 | 488.68 | 329.18 | 348.46 | 276.25 |
Total Debt | 203.84 | 79.89 | 82.12 | 141.42 | 154.44 | 102.92 |
Net Cash (Debt) | -67.82 | 7.75 | 21.03 | -90.07 | -67.92 | -51.83 |
Net Cash Growth | - | -63.17% | - | - | - | - |
Net Cash Per Share | -0.28 | 0.03 | 0.09 | -0.40 | -0.34 | -0.37 |
Filing Date Shares Outstanding | 223.98 | 238.16 | 237.62 | 228.22 | 222.16 | 195.92 |
Total Common Shares Outstanding | 225.36 | 237.87 | 236.62 | 226.06 | 221.82 | 195.81 |
Working Capital | 452.45 | 396.97 | 275.87 | 207.21 | 231.14 | 178.35 |
Book Value Per Share | 1.81 | 2.01 | 1.48 | 0.60 | 0.69 | 0.72 |
Tangible Book Value | 404.1 | 473.16 | 345.03 | 131.18 | 147.43 | 135.91 |
Tangible Book Value Per Share | 1.79 | 1.99 | 1.46 | 0.58 | 0.66 | 0.69 |
Land | 13.04 | 13.04 | 4.34 | 4.34 | 4.34 | 4.34 |
Buildings | 27.6 | 26.89 | 21.79 | 20.22 | 19.54 | 19.07 |
Machinery | 41.88 | 40.04 | 32.92 | 32.93 | 29.2 | 24.17 |
Construction In Progress | 10.82 | 8.46 | 8.15 | 2.27 | 6.73 | 5.5 |
Leasehold Improvements | 15.05 | 14.98 | 21.07 | 20.81 | 17.93 | 11.13 |